INSP - Inspire Medical Systems, Inc.

NYSE - NYSE Delayed Price. Currency in USD

Inspire Medical Systems, Inc.

5500 Wayzata Boulevard
Suite 1600
Golden Valley, MN 55416
United States

IndustryMedical Devices
Full Time Employees165

Key Executives

NameTitlePayExercisedYear Born
Mr. Timothy P. HerbertCEO, Pres & Director836.76kN/A1963
Mr. Richard BuchholzChief Financial Officer501.87kN/A1968
Mr. Randy BanChief Commercial Officer525.35kN/A1965
Mr. John RondoniVP of Product Devel., Operations & QualityN/AN/AN/A
Mr. Steven JandrichVP of HR & Chief Compliance OfficerN/AN/A1967
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was founded in 2007 and is headquartered in Golden Valley, Minnesota.

Corporate Governance

Inspire Medical Systems, Inc.’s ISS Governance QualityScore as of July 29, 2019 is 9. The pillar scores are Audit: 1; Board: 8; Shareholder Rights: 8; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.